Erythropoiesis stimulating agents are associated with serum fibroblast growth factor 23 metabolism in patients on hemodialysis

BACKGROUND: This study aimed to determine associations among short- and long-acting erythropoiesis stimulating agents (ESAs), changes in serum fibroblast growth factor 23 (FGF23) and biomarkers of iron metabolism. METHODS: Among 108 patients on hemodialysis (HD), 44 received every 2 weeks or monthly...

Descripción completa

Detalles Bibliográficos
Autores principales: Honda, Hirokazu, Tanaka, Kenji, Michihata, Tetsuo, Shibagaki, Keigo, Yuza, Toshitaka, Hirao, Keiichi, Tomosugi, Naohisa, Ganz, Tomas, Higashimoto, Yuichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986323/
https://www.ncbi.nlm.nih.gov/pubmed/33777378
http://dx.doi.org/10.1093/ckj/sfaa042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986323/
https://www.ncbi.nlm.nih.gov/pubmed/33777378
http://dx.doi.org/10.1093/ckj/sfaa042

Ejemplares similares